AC
PGEN icon

Apella Capital’s Precigen PGEN Stock Holding History

Apella Capital’s Portfolio PGEN Stock Details PGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$160K Hold
28,985
– – ﹤0.01% 680
2026
Q1 		$115K Hold
28,985
– – ﹤0.01% 662
2025
Q4 		$121K Hold
28,985
– – ﹤0.01% 524
2025
Q3 		$101K Hold
28,985
– – ﹤0.01% 466
2025
Q2 		$46.1K Hold
28,985
– – ﹤0.01% 417
2025
Q1 		$40.3K Buy
+28,985
New +$45.6K ﹤0.01% 383

Other funds holding PGEN

PCM
Patient Capital Management Baltimore, Maryland $3.05B AUM 42.09% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
DC
Diametric Capital Boston, Massachusetts $948M AUM 47.49% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
IAM
Iridian Asset Management Westport, Connecticut $291M AUM 49.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Apella Capital's PGEN Position: Q2 2026 in Review

Apella Capital held its Precigen (PGEN) position steady in Q2 2026 at 28,985 shares worth $160K. The position accounts for ﹤0.01% of the portfolio, ranked #680.

Apella Capital first reported a position in PGEN in Q1 2025 and has held it in 6 quarters since. 211 funds tracked by Wall St. Rank hold PGEN as of Q2 2026.

  • Apella Capital held 28,985 shares of Precigen worth $160K as of Q2 2026.
  • Apella Capital left its Precigen share count unchanged in Q2 2026.
  • Precigen made up ﹤0.01% of Apella Capital's portfolio in Q2 2026, its #680 holding.
  • Apella Capital first reported a position in Precigen in Q1 2025 and has held it in 6 quarters since.
  • 211 funds tracked by Wall St. Rank held Precigen as of Q2 2026.

Based on Apella Capital's 13F filing for Q2 2026, filed 8 Jul 2026.